- Home
- QSR vs ROIV Comparison
QSR vs ROIV Comparison
Compare QSR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QSR | ROIV |
|---|---|---|
| Founded | 1954 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 20.7B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QSR | ROIV |
|---|---|---|
| Price | $78.76 | $29.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 9 |
| Target Price | ★ $78.25 | $28.94 |
| AVG Volume (30 Days) | 2.7M | ★ 4.3M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.35 | N/A |
| Revenue | ★ $9,434,000,000.00 | $29,053,000.00 |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $2.21 | $744.61 |
| P/E Ratio | $33.33 | ★ N/A |
| Revenue Growth | ★ 12.23 | N/A |
| 52 Week Low | $61.33 | $10.18 |
| 52 Week High | $79.53 | $30.33 |
Technical Indicators
Market Signals| Indicator | QSR | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 64.58 | 57.64 |
| Support Level | $66.58 | $20.46 |
| Resistance Level | N/A | $30.33 |
| Average True Range (ATR) | 1.45 | 0.90 |
| MACD | 0.11 | 0.13 |
| Stochastic Oscillator | 88.49 | 71.77 |
Price Performance
Historical ComparisonAbout QSR Restaurant Brands International Inc.
Restaurant Brands generates about $44 billion in system sales across more than 32,000 restaurants in over 120 markets, making it one of the largest restaurant companies globally. Its banners include Burger King (7,082 stores), Tim Hortons (4,539), Popeyes (3,520), and Firehouse Subs (1,345), concentrated in the US and Canada, with these brands also comprising 15,639 franchised international locations as of year-end 2024. The firm primarily earns revenue from franchise and property fees, supply chain sales within the Tim Hortons segment, company-operated restaurants, and advertising royalties.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.